Although there is considerable evidence suggesting that Nrf2 activation is both safe to use and effective against several other diseases, it is essential to further investigate whether chronic, long-term Nrf2 activation therapy increases the risk of cancer development. This evidence concerns the gene NFE2L2 and cancer.